Barry Ticho, CHIEF MEDICAL OFFICER at Stoke Therapeutics, Inc. (STOK), sold 10,686 shares at $23.64 ($253K) on 2025-10-01, disclosed to the SEC on 2025-10-03.
Scheduled sale ($253k) by CHIEF MEDICAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $23.64 | 5,343 | $126K | 50.0% |
| 2 | $23.64 | 5,343 | $126K | 50.0% |
| Total | $23.64 avg | 10,686 | $253K | 100% |
| Filing → |
| STOK | SELL | 2026-08-18 | $153K | — | Filing → |
| STOK | SELL | 2026-08-05 | $208K | — | Filing → |
| STOK | SELL | 2026-07-06 | $236K | — | Filing → |